SCHEDULE 13D

Company

Jasper Therapeutics, Inc.

Filed

February 27, 2023

Accession Number

0000921895-23-000611

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →